Chemclin Diagnostics Co.Ltd(688468) announced that the shareholders Hengqin Junlian Zhikang and loyal class plan to reduce the shares of the company through centralized bidding and block trading, with a total reduction of no more than 20050000 shares and no more than 5% of the total share capital of the company. Shanghai Peixi and HJ capital plan to reduce the shares of the company through centralized bidding and block trading, with a total reduction of no more than 24060000 shares and no more than 6% of the total share capital of the company.